By contrast, lower expression of RPL29, the one belongs to the NDP, is predicted to have a poorer outcome of unresectable pancreatic cancer (38), providing further evidence that RPL29 might be anti-tumorigenic. This evidence concerns the gene RPL29 and pancreatic neoplasm.